← Leaderboards
Kathleen M Mulder
Pennsylvania State Univ Hershey Med Ctr
$8,877,651
Attributed
$9,094,841
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $925K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$9,094,841 · 6
By mechanism
R01$8,294,408 · 4
R21$800,433 · 2
Top collaborators
- Lance A Liotta2 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Robert Levenson$5,758,957
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationNeoplastic CellDynein AtpaseMediatingMicrotubulesSignal TransductionProteinsMalignant NeoplasmsIn VivoCancer CellTumorPlayComplexEventCellsRegulationBinding (Molecular Function)MotorLightLinkMitogen Activated Protein KinaseMutantReceptorIn Vitro
Grant awards (33)
Targeting Rab6-km23-1-mediated compartmentalized trafficking as a novel therapeutic approach to Alzheimers Disease$191,365
R21 · FY2019 · AG · contact PI
Targeting Rab6-km23-1-mediated compartmentalized trafficking as a novel therapeutic approach to Alzheimers Disease$243,015
R21 · FY2018 · AG · contact PI
Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells$166,388
R21 · FY2015 · CA · contact PI
Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells$199,665
R21 · FY2014 · CA · contact PI
Mechanisms of TGF-Beta Production in Human Cancer Cells$300,765
R01 · FY2011 · CA · contact PI
Role of TGFbeta in Microtubule Dynamics$259,680
R01 · FY2011 · CA · contact PI
Mechanisms of TGF-Beta Production in Human Cancer Cells$310,067
R01 · FY2010 · CA · contact PI
Role of TGFbeta in Microtubule Dynamics$269,269
R01 · FY2010 · CA · contact PI
Role of TGFbeta in Microtubule Dynamics$349,254
R01 · FY2009 · CA · contact PI
Mechanisms of TGF-Beta Production in Human Cancer Cells$310,067
R01 · FY2009 · CA · contact PI
Role of TGFbeta in Microtubule Dynamics$265,650
R01 · FY2009 · CA · contact PI
Mechanisms of TGF-Beta Production in Human Cancer Cells$310,067
R01 · FY2008 · CA · contact PI
Role of TGFbeta in Microtubule Dynamics$259,572
R01 · FY2008 · CA · contact PI
Role of Km23 in Ovarian Cancer$315,822
R01 · FY2007 · CA · contact PI
Mechanisms of TGF-Beta Production in Human Cancer Cells$301,958
R01 · FY2007 · CA · contact PI
Role of TGFbeta in Microtubule Dynamics$255,673
R01 · FY2007 · CA · contact PI
Role of Km23 in Ovarian Cancer$325,255
R01 · FY2006 · CA · contact PI
Mechanisms of TGFbeta Production in Human Cancer Cells$43,198
R01 · FY2006 · CA · contact PI
Role of Km23 in Ovarian Cancer$333,083
R01 · FY2005 · CA
Mechanisms of TGFbeta Production in Human Cancer Cells$319,343
R01 · FY2005 · CA
Role of TGFBeta in Microtubule Dynamics$255,474
R01 · FY2005 · CA
Role of Km23 in Ovarian Cancer$333,083
R01 · FY2004 · CA
Mechanisms of TGFbeta Production in Human Cancer Cells$319,343
R01 · FY2004 · CA
Role of TGFBeta in Microtubule Dynamics$255,474
R01 · FY2004 · CA
Role of Km23 in Ovarian Cancer$391,668
R01 · FY2003 · CA
Mechanisms of TGFbeta Production in Human Cancer Cells$319,343
R01 · FY2003 · CA
Role of TGFBeta in Microtubule Dynamics$255,474
R01 · FY2003 · CA
Mechanisms of TGFbeta Production in Human Cancer Cells$287,408
R01 · FY2002 · CA
Role of TGFBeta in Microtubule Dynamics$255,474
R01 · FY2002 · CA
Mechanisms of TGFbeta Production in Human Cancer Cells$287,408
R01 · FY2001 · CA
MECHANISMS OF TGF BETA SIGNALING$278,891
R01 · FY2001 · CA
Role of TGFBeta in Microtubule Dynamics$255,474
R01 · FY2001 · CA
MECHANISMS OF TGF BETA SIGNALING$271,171
R01 · FY2000 · CA